Public events

The Koch Institute is proud to be a part of the wider Cambridge and Kendall Square communities. We invite audiences of all ages and backgrounds to engage with the research happening in our laboratories through programs such as our with/in/sight public lecture series, exhibit-oriented events in the Koch Institute Public Galleries, and family-friendly activities organized as part of the annual Cambridge Science Festival.

Our public events portfolio includes virtual and hybrid programming to ensure that our extended community across the country, and indeed the world, has access to the latest research coming out of Koch Institute laboratories.

Public Events

Community Programs 

Our community programs showcase the work of Koch Institute researchers and their collaborations with clinicians, biopharmaceutical companies, and start-ups through presentations and networking.

Image Awards 

Hosted each March, this celebration honors the winners of the Koch Institute Image Awards competition and reveals the latest exhibition in the Koch Institute Public Galleries.

Cambridge Science Festival 

Every April, the Koch Institute offers visitors of all ages access to immersive, hands-on activities inspired by the Koch Institute’s dynamic cancer research.

Recent Highlights

The 2022 Albert Lasker Basic Medical Research Award 

Award Lecture and Fireside Chat Featuring Professor Richard Hynes

We invite the MIT community to join us on Wednesday, November  2, 2022, 4:00 p.m. to celebrate Professor Richard Hynes on his receipt of the 2022 Albert Lasker Basic Medical Research Award.

Rena Selya’s Salvador Luria 

Join us  on October 26, 2022, 5:30 p.m. to discuss Rena Selya’s biography of Salvador Luria with Deborah Douglas, Richard Hynes & Phillip Sharp.

Koch Institute Directors Panel 

December 14, 2021

Current and former directors reflect on the past five decades of progress and look ahead to future advancements in the fight against cancer. 

A Conversation with the New KI Director 

April 29, 2021

After his appointment as the fifth director of MIT's NCI-designated cancer research program, Matthew Vander Heiden joins MIT President Emerita Susan Hockfield in a virtual conversation about his vision for cancer research at MIT.